Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
Nave S, Doody RS, Boada M, Grimmer T, Savola J-M, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, et al.
